NCT01775293

Brief Summary

The aim of this study is to evaluate the efficacy and safety of the investigational device, RPM,non-absorbable polypropylene mesh made by D Med, in correction of Nasolabial fold. Study hypothesis

  • level of significance: alpha=0.05( two-side)
  • power of test: (power= 1-beta),power=0.08
  • H0: P equals P0
  • H1: P unequals P0
  • The difference between the changes in the WSRS(Wrinkle Severity Rating Scale) of the pre and post rhytidectomy from baseline at 7week after administration is 0.237( P-P0= 0.237)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

January 22, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 24, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 7, 2014

Status Verified

January 1, 2014

Enrollment Period

11 months

First QC Date

January 22, 2013

Last Update Submit

January 6, 2014

Conditions

Keywords

Non-absorbable polypropylene meshWSRSRhytidectomy

Outcome Measures

Primary Outcomes (1)

  • The change in the WSRS(Wrinkle Severity Rating Scale) of the pre and post rhytidectomy from baseline at 7week after administration

    The efficacy is assessed by the severity of the fold determined by the WSRS assessed by the investigator with photos WSRS(Wrinkle Severity Rating Scale)is be evaluated from 1 to 5 according to the severity of wrinkles (1= no visible fold, 5= extremely deep and long fold)

    change in the WSRS from baseline at7 week

Secondary Outcomes (1)

  • The changes in the satisfaction of the pre and post rhytidectomy from baseline at 7week after administration

    Changes Satisfaction from baseline at 7week

Study Arms (1)

Non-absorbable polypropylene mesh

EXPERIMENTAL

2 step procedures * first step is insertion of Non-absorbable polypropylene mesh under the facial skin * second step is pulling of Non-absorbable polypropylene mesh after 3 weeks of 1 step

Device: Non-absorbable polypropylene mesh

Interventions

2 step procedures * first step is insertion of Non-absorbable polypropylene mesh under the facial skin * second step is pulling of Non-absorbable polypropylene mesh after 3 weeks of 1 step

Non-absorbable polypropylene mesh

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects who had soft tissue sagging around nasolabial fold
  • Female aged between 30 and 65, having grade 3 or 4 of nasolabial fold as Wrinkle severity Rating Scale(WSRS)
  • Subjects who voluntary decided to participate in the study and signed the informed consent

You may not qualify if:

  • Subjects who have a skin disease on the face
  • Subjects who have severe facial skin disease
  • Subjects who are constantly taking anti-coagulants including aspirin
  • Subjects who have too thin or thick skin
  • Subjects who have a systemic disease such as uncontrolled high blood pressure, diabetes, heart disease
  • Subjects who had an allergy to non-absorbable material.
  • Subjects who are taking immune suppressants
  • General weakness status
  • Pregnant or lactating women
  • Subjects who have an asthma, cancer, AIDS, Cystic fibrosis, Immobility cilia syndrome, leukopenia, Immunoglobulin deficiency, active infectious disease, serious liver or renal disease,
  • Subjects who had a history of dermal augmentation surgery with permanent implants(e.g. silicone, Softform®)on the face
  • Subjects who participated in other clinical trial within 30 days from screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Korea University Anam Hospital

Seoul, Seongbukgu/Seoul, 136-705, South Korea

Location

Study Officials

  • Chanyeong Heo, Master

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2013

First Posted

January 24, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2013

Study Completion

January 1, 2014

Last Updated

January 7, 2014

Record last verified: 2014-01

Locations